CV Sciences (CVSI) Total Liabilities (2010 - 2026)
CV Sciences' (CVSI) quarterly Total Liabilities came in at $5.2 million in Q1 2026, down 10.99% year-on-year from $5.9 million in Q1 2025, and down 4.91% quarter-over-quarter from $5.5 million in Q4 2025.
CV Sciences (CVSI) Total Liabilities (2010 - 2026) Analysis & Trends
CV Sciences has disclosed Total Liabilities across 17 years of filings, most recently posting $5.2 million for Q1 2026.
- Total Liabilities for Q1 2026 came in at $5.2 million, down 10.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.2 million (down 10.99% YoY), and the FY2025 annual result was $5.5 million, down 10.4% from the prior year.
- Total Liabilities came in at $5.2 million for Q1 2026 at CV Sciences, down from $5.5 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $14.3 million in Q1 2022 to a low of $5.2 million in Q1 2026.
- The 5-year median for Total Liabilities is $6.2 million (2023), against an average of $7.8 million.
- Across the five-year window, Total Liabilities advanced 10.81% in 2022 and sank 56.84% in 2023, its largest moves.
- CV Sciences' Total Liabilities stood at $13.5 million in 2022, then tumbled by 53.4% to $6.3 million in 2023, then retreated by 2.62% to $6.1 million in 2024, then retreated by 10.4% to $5.5 million in 2025, then slipped by 4.91% to $5.2 million in 2026.
- The last three Total Liabilities figures came in at $5.2 million (Q1 2026), $5.5 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 31.81 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 11.92 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 813.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 148.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.50 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.72 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.51 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.13 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.82 Bn |
| 10 | CV Sciences | - | - | 1.56 Mn | 5.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.22 Mn |
| Dec 31, 2025 | 5.49 Mn |
| Sep 30, 2025 | 5.46 Mn |
| Jun 30, 2025 | 6.15 Mn |
| Mar 31, 2025 | 5.87 Mn |
| Dec 31, 2024 | 6.13 Mn |
| Sep 30, 2024 | 6.20 Mn |
| Jun 30, 2024 | 6.38 Mn |
| Mar 31, 2024 | 6.10 Mn |
| Dec 31, 2023 | 6.30 Mn |
| Sep 30, 2023 | 6.16 Mn |
| Jun 30, 2023 | 5.99 Mn |
| Mar 31, 2023 | 6.42 Mn |
| Dec 31, 2022 | 13.51 Mn |
| Sep 30, 2022 | 13.82 Mn |
| Jun 30, 2022 | 13.87 Mn |
| Mar 31, 2022 | 14.26 Mn |
| Dec 31, 2021 | 14.52 Mn |
| Sep 30, 2021 | 12.47 Mn |
| Jun 30, 2021 | 17.83 Mn |